is a seed VC fund investing in startups developing best-in-class medicines

Mary is founding managing partner of BioRock Ventures in the Bay Area, CA. Mary began two decades of operating experience as a therapeutics startup founder in Boston. She moved to roles leading negotiations, business and technical evaluations for M&A and licensing deals as well as strategy roles at large and medium pharmaceuticals companies like Johnson & Johnson and Forest, now Allergan/Abbvie, in NYC. She also has served as consulting CBO for several dozen early stage ventures around the world. She began venture investing a decade ago where she helped form and put first money into two new companies which each had IPO exits valued over $1 Billion.

Mary is a Kauffman Fellow, earned an MBA from MIT Sloan, a PhD from Princeton University and an undergraduate degree from Yale University.